22 high-tech toys grown-ups will love Don't put away childish things, embrace your inner kid and rediscover toy joy T3 · Jul 22
This point-and-shoot camera helped me ditch my smartphone After decades of digital photography, film is on the up, and this brand is making it easier than ever to do it The Independent UK · Jul 7
Why Is Eye Disease Focused Kala Bio Stock Plunging On Monday? Kala Bio Inc. (NASDAQ: KALA) stock is down on Monday after the company halted development of its experimental treatment for a specific eye condition. Benzinga · Sep 29, 2025
5 Healthcare Stocks On Fire This Week Five healthcare stocks have emerged as standout performers, posting remarkable week-on-week momentum gains according to the latest Benzinga Edge Ranking report. Benzinga · Aug 21, 2025
Christmas gifts for musicians and aspiring rock stars T3's guide to the best gifts for those who like to rock and or roll T3 · Dec 9, 2024
The Antipodes Oladra is a high-end music server with a sky high price The Antipodes Oladra music server costs as much as a Volkswagen Golf, but it promises life-changing performance. What Hi-Fi? · Sep 16, 2024
Acclaimed chef's genius response to swipe that new pub 'will only last six months' He delivered the perfect riposte to a critic Manchester Evening News · Jan 22, 2023
Chef Gary Usher drops big hint over new dog friendly pub opening date The Elite Bistros founder, which owns Hispi in East Didsbury and Kala in Manchester, became the owner of the White Horse pub back in October Manchester Evening News · Dec 29, 2022
Three Greater Manchester eateries named in Top 100 Restaurants in the UK OpenTable's annual list spotlights some of the most beloved restaurants in the UK Manchester Evening News · Dec 9, 2022
Chef Gary Usher saved treasured village pub from developers who planned to knock it down and build flats The chef behind Hispi and Kala will open The White Horse in Churton Manchester Evening News · Oct 10, 2022
The Mancunian Way: Manky or swanky? Read the Mancunian Way newsletter for Thursday October 6, 2022. Manchester Evening News · Oct 6, 2022
Hispi and Kala owner Gary Usher raises £126,000 in 12 hours in new restaurant crowdfund Fans of his business are staking their claim Manchester Evening News · Aug 2, 2022
Why Kala Pharmaceuticals Shares Are Rising Today Kala Pharmaceuticals Inc (NASDAQ: KALA) shares are trading higher after the company said it would sell its EYSUVIS and INVELTYS treatments for $60 million. Benzinga · May 23, 2022
Earnings Preview For Kala Pharmaceuticals Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Kala Pharmaceuticals will report an earnings per share (EPS) of $-0.36. Benzinga · May 13, 2022
Benzinga · May 2, 2022 Kala Pharmaceuticals Posts KPI-012 Data In Healing Impaired Ocular Diseases Kala Pharmaceuticals Inc (NASDAQ:KALA) reported data from a Phase 1b trial of KPI-012, a cell-free secretome therapy for severe ocular diseases driven by impaired healing. As previously disclosed, KPI-012 was well tolerated and resulted in significant improvements in various persistent corneal epithelial defect (PCED) etiologies. The data will be presented at the 2022…
Benzinga · Mar 30, 2022 Kala Pharmaceuticals's Return On Capital Employed Insights Benzinga Pro data, Kala Pharmaceuticals (NASDAQ:KALA) reported Q4 sales of $1.86 million. Earnings fell to a loss of $47.57 million, resulting in a 69.12% decrease from last quarter.
Benzinga · Mar 29, 2022 Recap: Kala Pharmaceuticals Q4 Earnings Kala Pharmaceuticals (NASDAQ:KALA) reported its Q4 earnings results on Tuesday, March 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Benzinga · Mar 28, 2022 Earnings Outlook For Kala Pharmaceuticals Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Kala Pharmaceuticals will report an earnings per share (EPS) of $-0.41.
Benzinga · Mar 24, 2022 How To Attend Kala Pharmaceuticals Q4 2021 Earnings Conference Call Kala Pharmaceuticals (NASDAQ:KALA) will host a conference call at 08:00 AM ET on March 29, 2022, to discuss Q4 2021 earnings results. How to Attend Kala Pharmaceuticals (KALA) Conference Call Follow this link to access the live webcast.
Benzinga · Mar 8, 2022 This Microcap Pharma Stock Almost Doubled Today - Read Why UnitedHealthcare has added Kala Pharmaceuticals Inc's (NASDAQ:KALA) Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% as a covered brand on its commercial formularies effective March 2022. Eysuvis now has coverage for approximately 118 million lives or 70% of all commercial lives. Kala also announced that Cigna Medicare had added Eysuvis as a preferred brand effective…
Manchester Evening News · Feb 18, 2022 Elite Bistros' boss Chef Gary Usher is planning to offer shares in his new business The boss of Kala and Hispi is opening a new pub too